Next Article in Journal
Clinical Results of Hypomethylating Agents in AML Treatment
Previous Article in Journal
Inflammation and Cell Death in Age-Related Macular Degeneration: An Immunopathological and Ultrastructural Model
Previous Article in Special Issue
Obesity as an Early Symptom of the AMIS Syndrome
Article Menu

Export Article

Open AccessReview
J. Clin. Med. 2014, 3(4), 1561-1574; doi:10.3390/jcm3041561

The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus

1
School of Health Nursing & Midwifery, the University of the West of Scotland, Paisley PA1 2BE, UK
2
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm SE171 76, Sweden
*
Author to whom correspondence should be addressed.
Received: 23 September 2014 / Revised: 21 November 2014 / Accepted: 5 December 2014 / Published: 22 December 2014
(This article belongs to the Special Issue Obesity, Diabetes and Metabolic Syndrome)
View Full-Text   |   Download PDF [195 KB, uploaded 22 December 2014]   |  

Abstract

The insulin-like growth factor (IGF) system, acting in concert with other hormone axes, is important in normal metabolism. In obesity, the hyperinsulinaemia that accompanies peripheral insulin resistance leads to reduced growth hormone (GH) secretion, while total IGF-I levels are relatively unchanged due to increased hepatic GH sensitivity. IGF-binding protein (IGFBP)-1 levels are suppressed in relation to the increase in insulin levels in obesity and low levels predict the development of type 2 diabetes several years later. Visceral adiposity and hepatic steatosis, along with a chronic inflammation, contribute to the IGF system phenotype in individuals with metabolic syndrome and type 2 diabetes mellitus, including changes in the normal inverse relationship between IGFBP-1 and insulin, with IGFBP-1 concentrations that are inappropriately normal or elevated. The IGF system is implicated in the vascular and other complications of these disorders and is therefore a potential therapeutic target. View Full-Text
Keywords: insulin-like growth factor; IGFBP; GH; obesity; type 2 diabetes insulin-like growth factor; IGFBP; GH; obesity; type 2 diabetes
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Lewitt, M.S.; Dent, M.S.; Hall, K. The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus. J. Clin. Med. 2014, 3, 1561-1574.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top